Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Explore this paper's citation graph
Summary
Peptide levels predicted the risk of death and cardiovascular events after adjustment for traditional risk factors and excess risk was apparent at natriuretic peptide levels well below current thresholds used to diagnose heart failure.
- Type
- article
- Published
- 2004-02-12
- Cited by
- 1,427
- References
- 44
- Access
- Open access
- OpenAlex
- https://openalex.org/W14960742
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19238532
Keywords
Humanities, Political science, Art
References
- Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements
- Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.
- The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
- Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
- Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
- Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
- Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
- Increased cardiac BNP expression associated with myocardial ischemia
- A friend within the heart: natriuretic peptide receptor signaling.
- Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly.
- B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
- Probability of stroke: a risk profile from the Framingham Study.
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
- Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat.
- The natriuretic peptides
- Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
- The gene encoding atrial natriuretic peptide and the risk of human stroke.
- A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
- Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons.
Cited by
- Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers
- Cardiovascular risk stratification in older patients: role of brain natriuretic peptide, C-reactive protein, and urinary albumin levels.
- Cardiovascular and metabolic effects of natriuretic peptides
- Disease management programs for heart failure: Not just for the ‘sick’ heart failure population
- Natriuretic peptides and cardiovascular events: more than a stretch.
- Brain natriuretic peptide testing for angina in a rapid-access chest pain clinic.
- Natriuretic peptides ... they're not just for adults anymore.
- Comparison of the Utility of Preoperative versus Postoperative B-type Natriuretic Peptide for Predicting Hospital Length of Stay and Mortality after Primary Coronary Artery Bypass Grafting
- The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays.
- Atrial natriuretic peptide as a predictor of atrial fibrillation in a male population study. The Study of Men Born in 1913 and 1923.
- N‐terminal pro–brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk
- Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy
- Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
- Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
- Фазы формирования аллостаза у юных спортсменов, детерминированные средовыми воздействиями и факторами риска
- Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006.
- Racial differences in the prevalence of atrial fibrillation among males.
- Síndrome coronario agudo: Marcadores de lesión miocárdica
- Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.
- Breathing not properly 10 years later: what we have learned and what we still need to learn.
Related papers
No related papers recorded.